Correlation Between ConnectOne Bancorp and Talaris Therapeutics

Can any of the company-specific risk be diversified away by investing in both ConnectOne Bancorp and Talaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ConnectOne Bancorp and Talaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ConnectOne Bancorp and Talaris Therapeutics, you can compare the effects of market volatilities on ConnectOne Bancorp and Talaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ConnectOne Bancorp with a short position of Talaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ConnectOne Bancorp and Talaris Therapeutics.

Diversification Opportunities for ConnectOne Bancorp and Talaris Therapeutics

0.61

Correlation Coefficient

ConnectOne Bancorp  Talaris Therapeutics

Poor diversification

The 3 months correlation between ConnectOne and Talaris is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding ConnectOne Bancorp and Talaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talaris Therapeutics and ConnectOne Bancorp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ConnectOne Bancorp are associated (or correlated) with Talaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talaris Therapeutics has no effect on the direction of ConnectOne Bancorp i.e., ConnectOne Bancorp and Talaris Therapeutics go up and down completely randomly.

Pair Corralation between ConnectOne Bancorp and Talaris Therapeutics

If you would invest  2,216  in ConnectOne Bancorp on September 24, 2024 and sell it today you would earn a total of  10.00  from holding ConnectOne Bancorp or generate 0.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	5.0%
Values	Daily Returns

ConnectOne Bancorp  vs.  Talaris Therapeutics

ConnectOne Bancorp

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in ConnectOne Bancorp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable fundamental drivers, ConnectOne Bancorp is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Talaris Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Talaris Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Talaris Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with ConnectOne Bancorp and Talaris Therapeutics

The main advantage of trading using opposite ConnectOne Bancorp and Talaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ConnectOne Bancorp position performs unexpectedly, Talaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talaris Therapeutics will offset losses from the drop in Talaris Therapeutics' long position.

The idea behind ConnectOne Bancorp and Talaris Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.